Multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology

Over the last two decades concern about influenza has increased worldwide due to the rising number of human infections caused by an avian virus, H5N1, and the 2009-pandemic of swine-origin H1N1 virus. Counter-measures, for example the selective administration of antivirals to infected individuals, t...

Full description

Bibliographic Details
Main Author: d'Episcopo, Lorenzo
Other Authors: Crisanti, Andrea
Published: Imperial College London 2013
Subjects:
572
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.602289
id ndltd-bl.uk-oai-ethos.bl.uk-602289
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6022892017-06-27T03:23:31ZMultiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technologyd'Episcopo, LorenzoCrisanti, Andrea2013Over the last two decades concern about influenza has increased worldwide due to the rising number of human infections caused by an avian virus, H5N1, and the 2009-pandemic of swine-origin H1N1 virus. Counter-measures, for example the selective administration of antivirals to infected individuals, their hospitalization, and the culling of large numbers of infected animals require a prompt and reliable diagnosis, that ideally identifies the type and subtype of the virus and can be carried out at the Point-of-Care (POC). Nowadays instead diagnosis is still largely laboratory-bound, as the available POC-suitable tests are hampered by poor and very variable clinical sensitivity. This PhD was developed in the frame of a European joint effort (Fluarray) that aimed at constructing an automated diagnostic system for the rapid influenza diagnosis. Key technology of the system is an antibody microarray technology that permits the simultaneous analysis of hundreds of antigen-antibody interactions. This research investigated ways to detect the influenza virus using a panel of monoclonal antibodies that were purified, characterized and integrated into the microarray platform. The optimised immunoassay detects and differentiates the influenza nucleoproteins of type A and B at concentrations in the order of few nanograms/ml. A panel of influenza viruses were detected and their type identified within 1 hour hands-on time. The developed microarray platform will soon be integrated into an Automated Diagnostic Analyser for Microarrays (ADAM) developed by the collaborating partner Microtest Matrices. It is envisaged that the system will be a consistent aid in the influenza diagnosis and sensibly facilitate and speed up diagnostic procedures.572Imperial College Londonhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.602289http://hdl.handle.net/10044/1/13691Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 572
spellingShingle 572
d'Episcopo, Lorenzo
Multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology
description Over the last two decades concern about influenza has increased worldwide due to the rising number of human infections caused by an avian virus, H5N1, and the 2009-pandemic of swine-origin H1N1 virus. Counter-measures, for example the selective administration of antivirals to infected individuals, their hospitalization, and the culling of large numbers of infected animals require a prompt and reliable diagnosis, that ideally identifies the type and subtype of the virus and can be carried out at the Point-of-Care (POC). Nowadays instead diagnosis is still largely laboratory-bound, as the available POC-suitable tests are hampered by poor and very variable clinical sensitivity. This PhD was developed in the frame of a European joint effort (Fluarray) that aimed at constructing an automated diagnostic system for the rapid influenza diagnosis. Key technology of the system is an antibody microarray technology that permits the simultaneous analysis of hundreds of antigen-antibody interactions. This research investigated ways to detect the influenza virus using a panel of monoclonal antibodies that were purified, characterized and integrated into the microarray platform. The optimised immunoassay detects and differentiates the influenza nucleoproteins of type A and B at concentrations in the order of few nanograms/ml. A panel of influenza viruses were detected and their type identified within 1 hour hands-on time. The developed microarray platform will soon be integrated into an Automated Diagnostic Analyser for Microarrays (ADAM) developed by the collaborating partner Microtest Matrices. It is envisaged that the system will be a consistent aid in the influenza diagnosis and sensibly facilitate and speed up diagnostic procedures.
author2 Crisanti, Andrea
author_facet Crisanti, Andrea
d'Episcopo, Lorenzo
author d'Episcopo, Lorenzo
author_sort d'Episcopo, Lorenzo
title Multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology
title_short Multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology
title_full Multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology
title_fullStr Multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology
title_full_unstemmed Multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology
title_sort multiplex point-of-care detection of human and avian influenza viruses using an antibody microarray technology
publisher Imperial College London
publishDate 2013
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.602289
work_keys_str_mv AT depiscopolorenzo multiplexpointofcaredetectionofhumanandavianinfluenzavirusesusinganantibodymicroarraytechnology
_version_ 1718465541441585152